BENEFIT Act of 2017

Summary

Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2017 or the BENEFIT Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to consider patient-focused drug development data, such as patient preferences, patient-reported outcomes, and patient experiences, as part of the risk-benefit assessment of new drugs. Following approval of a drug, the FDA must include a description of how this information was considered in its statement of patient experience.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

8 official files

• Referred in House (text)

  Referred in House · EN · 4 August 2017

  ViewDownloadOpen at official source

• Referred in House (PDF)

  Referred in House · EN · 4 August 2017

  ViewDownloadOpen at official source

• Engrossed in Senate (text)

  Engrossed in Senate · EN · 3 August 2017

  ViewDownloadOpen at official source

• Engrossed in Senate (PDF)

  Engrossed in Senate · EN · 3 August 2017

  ViewDownloadOpen at official source

• Passed Senate without amendment

  summary · EN · 3 August 2017

  Open at official source

• Introduced in Senate (text)

  Introduced in Senate · EN · 4 May 2017

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 4 May 2017

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 4 May 2017

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.